Two NEJM Papers Evaluate Imetelstat in Myelofibrosis and Essential Thrombocythemia

NCI releases names of members of ad hoc working group—filling the void left by BSA

NCI has released the names of the members of the newly formed ad hoc Working Group on Extramural Research Concepts and Programs. The group will perform the peer review functions of the now-defunct Board of Scientific Advisors.

September 19, 2025

By Sara Willa Ernst

AACR Cancer Progress Report makes the case for federal investment in cancer research

As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment.

September 19, 2025

By Sara Willa Ernst

Letter To The Editor

Urgently needed: A funding mechanism to insulate cancer research from political whims

Jonathan Mahler’s article in the Sept. 14 issue of The New York Times Magazine provided an excellent overview of the Trump administration’s assault on cancer research.

September 19, 2025

By Paul W. Thurman

Guest Editorial

How today’s uncertainty can motivate young investigators to double down on their passion
Lessons from my Studs Terkel boxed set

The Cancer Letter has published a number of excellent pieces lately on the importance of supporting and encouraging trainees and junior investigators during these uncertain times.

September 19, 2025

By George J. Weiner

Cancer Policy

Ousted CDC director testifies before Senate HELP Committee

Ousted from her position as director of the Centers for Disease Control and Prevention less than a month after her confirmation, Susan Monarez has now had the chance to tell her side of the story before Congress.

September 19, 2025

By Claire Marie Porter

Cancer Policy

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

At a two-day meeting, the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 8-3 to change the current recommendations that allow children under age 4 to receive the MMRV vaccine, a combination shot for measles, mumps, rubella and chickenpox (or varicella).

September 19, 2025

By Claire Marie Porter

Two NEJM Papers Evaluate Imetelstat in Myelofibrosis and Essential Thrombocythemia

YOU MAY BE INTERESTED IN

NCI releases names of members of ad hoc working group—filling the void left by BSA

AACR Cancer Progress Report makes the case for federal investment in cancer research

Urgently needed: A funding mechanism to insulate cancer research from political whims

How today’s uncertainty can motivate young investigators to double down on their passion
Lessons from my Studs Terkel boxed set

Ousted CDC director testifies before Senate HELP Committee

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

Renew today!

Subscriber content

Never miss an issue!

Login

Two NEJM Papers Evaluate Imetelstat in Myelofibrosis and Essential Thrombocythemia

YOU MAY BE INTERESTED IN

NCI releases names of members of ad hoc working group—filling the void left by BSA

AACR Cancer Progress Report makes the case for federal investment in cancer research

Urgently needed: A funding mechanism to insulate cancer research from political whims

How today’s uncertainty can motivate young investigators to double down on their passionLessons from my Studs Terkel boxed set

Ousted CDC director testifies before Senate HELP Committee

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

Never miss an issue!

Login

How today’s uncertainty can motivate young investigators to double down on their passion
Lessons from my Studs Terkel boxed set